Loading...
Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation
DNA vaccines are stable, safe, and cost effective to produce and relatively quick and easy to manufacture. However, to date, DNA vaccines have shown relatively poor immunogenicity in humans despite promising preclinical results. Consequently, a number of different approaches have been investigated t...
Saved in:
| Published in: | Vaccines (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6632145/ https://ncbi.nlm.nih.gov/pubmed/31200559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7020050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|